✦ LIBER ✦

281 Concurrent chemo-radiotherapy as intensification in limited (LD) small cell lung cancer (SCLC). A phase II trial

✍ Scribed by Crinò, L.; De Marinis, F.; Corgna, E.; Maranzano, E.; Figoli, F.; Contu, A.; Darwish, S.; Di Costanzo, F.; Tonato, M.

Book ID: 123318632
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 161 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89660-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EP-1221 RESULTS OF CONCURRENT HYPERFRACT

EP-1221 RESULTS OF CONCURRENT HYPERFRACTIONATED CHEMO-RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER (LD-SCLC)

✍ Monne, J. Sole; Gallardo, E.; Blanco, R.; Bastús, R.; Mesía, R.; Montesinos, J.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Intensification with high-dose (HD) chem

Intensification with high-dose (HD) chemotherapy and concurrent b.i.d. radiotherapy in limited (LD) small cell lung cancer (SCLC). Preliminary results of a phase II trial

✍ Crinò, L.; De Marinis, F.; Meacci, M.; Clerici, M.; Contu, A.; Bracarda, S.; Dar 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Isolated nodal failure after chemo-radio

Isolated nodal failure after chemo-radiotherapy in limited disease small cell lung cancer (LD-SCLC)

✍ Marek WIERZCHOWSKI; Arkadiusz SPRAWKA; Lucyna KĘPKA 📂 Article 📅 2009 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 183 KB

Evaluating the safety of using G-CSF pro

Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial

✍ Sheikh, H.Y.; Colaco, R.; Ashcroft, L.; Blackhall, F.H.; Lorigan, P.C.; Taylor, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Alternating versus sequential chemoradio

Alternating versus sequential chemoradiotherapy in Limited Small Cell Lung Cancer (SCLC). EORTC phase II trial

✍ Drings, P.; Gregor, A.; Burghouts, JTM.; Postmus, P.; Rinaldi, M.; Kirkpatrick, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,